Kings Research is delighted to announce the publication of its latest market research study on the Neurorehabilitation Devices Market was valued at USD 1.96 billion in 2022 and is projected to reach USD 5.63 billion by 2030, growing at a CAGR of 14.32% from 2023 to 2030. The global market is constantly evolving, and businesses need to stay up-to-date with the latest trends and developments in order to remain competitive.

Get PDF Sample Copy of Report: https://www.kingsresearch.com/request-sample/neurorehabilitation-devices-market-137

Competitive Landscape:

This competitive landscape is influenced by several factors, including technological advancements, shifting consumer preferences, regulatory frameworks, and economic conditions. Businesses operating in this market must stay vigilant to these influences to stay ahead in the competitive race. This study equips businesses with valuable information to assess their competitive environment and make well-informed business decisions.

Key Players: -

• AIMedical International Pty Ltd
• Ectron
• Ekso Bionics
• eodyne
• Evolution Devices
• Gloreha IDROGENET s.r.l.
• Helius Medical Technologies, Inc.
• Lupin
• Medtronic
• MindMaze
• Neurofenix, Inc.
• Sumitomo Pharma Co., Ltd.
• BIONIK

The report covers major market drivers, restraints, challenges, and opportunities, as well as emerging technologies, market trends, and technological integration, making sure the information stays up-to-date. It further provides an overview of the factors bolstering product sales, such as the introduction of novel features, rising investments in R&D activities, and expanding production capacities.

Market Segmentation

Segmentation analysis is a crucial tool for comprehending and analyzing the global market. This study report identifies segments by dividing the market into distinct categories based on characteristics like demographics, geographic location, psychographics, behavior, and preferences. Businesses can leverage this segmentation to effectively target specific customer groups by utilizing tailored marketing strategies and offerings that align with their unique needs and preferences.

By Product

• Neurorobotic Systems
• Brain-computer Interface
• Wearable Devices
• Brain Stimulators

By Application

• Stroke
• Brain & Spinal Cord Injury
• Parkinson’s Disease
• Cerebral Palsy
• Multiple Sclerosis
• Others

By End User

• Rehabilitation Centers
• Hospitals & Clinics
• Home Care
• Others

Browse More Information: - https://www.kingsresearch.com/neurorehabilitation-devices-market-137

It provides insights into critical factors that are fostering market development, along with the lucrative opportunities the global market holds. This involves favorable government policies, economic factors, trends, and numerous initiatives taken by corporations to augment product sales. The study will prove beneficial to manufacturers, new entrants, and businesses involved in the industry chain, offering valuable insights to support their operations and strategic initiatives.

The report highlights a comprehensive analysis of the competitive landscape of the global Neurorehabilitation Devices market, focusing on key players and strategic developments. The global market is characterized by dynamism and competitiveness, with companies seeking to gain market share and secure a competitive edge in the global industry.

Regional Insights

The North America will dominate the market share of Neurorehabilitation Devices Market. The regional outlook for different parts of the world, such as North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, is also included. The regional section sheds light on the prominent factors shaping market growth to assist stakeholders in understanding the global market standing of leading regions.

Enquiry about Reports: - https://www.kingsresearch.com/enquiry/neurorehabilitation-devices-market-137

Key Developments

• February 2023 (Product Launch): MindMaze launched Izar, which is US Food and Drug Administration (FDA)-listed and CE-marked smart peripheral device for patients with impaired hand motor skills. Izar is designed to fill a critical gap in neurological care and aims to be the most effective treatment for manual dexterity and strength in a wide range of neurological conditions.
• September 2021 (Product Launch): Evolution Devices launched EvoWalk Platform pilot program to restore walking to those with neurological partial ambulatory paralysis. The company's approach is designed to combine neurological remote physical therapy (PT) with EvoWalk, a smart stimulation device that helps patients avoid falls and restore instinctive movements.
• September 2022 (Partnership): Sumitomo Pharma Co., Ltd. and MELTIN MMI entered into an agreement with MELTz for marketing the MELTz product primarily in rehabilitation units to recover. This device is designed to support hand/finger motor function rehabilitation by combining algorithms that recognize myoelectric (biosignals) hand/finger movement signals with a robotic system that provides motor assistance based on the intended movements of the user.

About Us:

Kings Research stands as a renowned global market research firm. With a collaborative approach, we work closely with industry leaders, conducting thorough assessments of trends and developments. Our primary objective is to provide decision-makers with tailored research reports that align with their unique business objectives. Through our comprehensive research studies, we strive to empower leaders to make informed decisions.

Our team comprises individuals with diverse backgrounds and a wealth of knowledge in various industries. At Kings Research, we offer a comprehensive range of services aimed at assisting you in formulating efficient strategies to achieve your desired outcomes. Our objective is to significantly enhance your long-term progress through these tailored solutions.

Contact Us

Kings Research
Phone: (+1) 888 328 2189
E-mail: business@kingsresearch.com
Website: https://www.kingsresearch.com
Blog: https://www.kingsresearch.com/blog
Follow Us: LinkedIn | Facebook | Twitter